Home Editorials and Commentaries

Editorials and Commentaries

Editorials and Commentaries

A Spaceship on Mars and Screening for Gynecologic Cancer

Valena Wrtight, MD - April 6, 2021

Are Cytology and Imaging Adequate for the Diagnostic Management of Brain Metastasis?

Revealing the Blind Spot in Cancer Treatment with Host Response Profiling

Remembering Emil “Jay” Freireich—the Man Who Made Vince DeVita a ‘Believer’

How Good Communication and Transparency may Help avoid a Medical Malpractice Lawsuits

An Evolution to Genomic Testing for DCIS

Leonard A. Farber, MD - February 5, 2021

How Artificial Intelligence Helps Oncologists See and Act on Invisible Socioeconomic...

Amy Valley, PharmD - January 30, 2021

Changing the Conversation

Loretta T. Friedman, RN, MS, DC, CNS,DACBN - January 2, 2021

It’s a Good News-Bad News Kind of Thing…

Editorial Team - November 6, 2020

Doctor discussing treatment options with a patient.

Patient-First Specialty Rx Solutions Expedite Trials, Enhance Compliance and Improve Experience

Donovan Quill - October 14, 2020

Precision Technology Transforms the Way Leading Hospitals Diagnose and Treat ...

Steven Bardot, M.D. - September 16, 2020

Scientist working in the biosafety cabinet

Why Doctors Don’t Trust Cannabis

Sarah Dakar - June 11, 2020

Featured Image: Pipette with Cannabis oil. Photo Credit: © 2018 - 2020 Fotolia/Adobe

Providing the Legitimacy of Cannabinoids for the Treatment of Cancer

Guy Chamberland, M.Sc., Ph.D - June 8, 2020

The Value of Biosimilars in the Pandemic Era

Seongwon Han, M.D. - June 5, 2020

Featured Image: Research at Alkermes. Photo Courtesy: © 2020 Alkermes, Inc.

Re-Engineering Molecules to Drive Innovation in Cancer Immunotherapy

Heather Losey, Ph.D. - June 1, 2020

12 3...7 Page 1 of 7

LATEST NEWS

AmunBio and NorthShore University to Advance Cancer Immunotherapy with Engineered Oncolytic Viruses

Peter Hofland, Ph.D - April 13, 2021

Tebentafusp Significantly Improves Overall Survival in Patients With Metastatic Uveal Melanoma

Peter Hofland, Ph.D - April 11, 2021

Rare Pathogenic Germline Variants Linked to Worse Survival Outcomes in Neuroblastoma

Peter Hofland, Ph.D - April 11, 2021

CHRONOS-3 Trial: Combination of Copanlisib-Rituximab Reduces risk of Disease Progression in NHL

Danielle Garcia - April 11, 2021

Improving Accuracy in Predicting Response to Neoadjuvant Treatment in Patients With Breast Cancer

Danielle Garcia - April 11, 2021

Press Releases | Cancer

Society for Immunotherapy of Cancer Launches Online Seminar Series on... April 19, 2021
The Society for Immunotherapy of Cancer (SITC) is pleased to offer a highly anticipated series of live online seminars to address key questions in the field of cancer immunotherapy, both...(PRWeb April 19, 2021)Read the full story at https://www.prweb.com/releases/society_for_immunotherapy_of_cancer_launches_online_seminar_series_on_advanced_topics_in_immuno_oncology/prweb17874092.htm
Allegheny General Hospital Plastic Surgeons Among First in the Region... April 19, 2021
Plastic surgeons at Allegheny General Hospital (AGH), the flagship academic medical center of Allegheny Health Network (AHN), are now among the first in the region to perform innovative breast and...(PRWeb April 19, 2021)Read the full story at https://www.prweb.com/releases/allegheny_general_hospital_plastic_surgeons_among_first_in_the_region_to_perform_innovative_robotic_breast_colorectal_reconstruction_surgeries/prweb17874008.htm
MacroGenics Adopts Genedata Profiler to Enhance Development of... April 19, 2021
Emerging leader in immuno-oncology therapeutics implements innovative software platform to design smarter clinical trials and accelerate development of precision medicines.(PRWeb April 19, 2021)Read the full story at https://www.prweb.com/releases/macrogenics_adopts_genedata_profiler_to_enhance_development_of_immunotherapies/prweb17873268.htm